Novel peptide from spider venom inhibits P2X3 receptors and inflammatory pain

Annals of Neurology

Volumn 67, Issue 5, 2010, Pages 680-683

  Grishin, Eugene V ^a   Savchenko, Ganna A ^b   Vassilevski, Alexander A ^a   Korolkova, Yuliya V ^a   Boychuk, Yaroslav A ^b   Viatchenko Karpinski, Viacheslav Y ^b   Nadezhdin, Kirill D ^a   Arseniev, Alexander S ^a   Pluzhnikov, Kirill A ^a   Kulyk, Vyacheslav B ^b   Voitenko, Nana V ^b   Krishtal, Oleg O ^b  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

PRIANOSIN A; PURINERGIC P2X3 RECEPTOR; PUROTOXIN 1; SPIDER VENOM; UNCLASSIFIED DRUG;

ANTINOCICEPTION; ARTICLE; DESENSITIZATION; INFLAMMATION; PAIN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN STRUCTURE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CHONDRUS; CYTIDINE TRIPHOSPHATE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SPINAL; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE POTENTIALS; NEUROGENIC INFLAMMATION; PAIN; PATCH-CLAMP TECHNIQUES; PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2; SENSORY RECEPTOR CELLS; SPIDER VENOMS; TRANSFECTION;

EID: 77951738339     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21949     Document Type: Article

References (18)

1. Kennedy C. P2X receptors: targets for novel analgesics? Neuroscientist 2005;11:345-356.
2. Khakh BS, North RA. P2X receptors as cell-surface ATP sensors in health and disease. Nature 2006;442:527-532.
3. Abbracchio MP, Burnstock G, Verkhratsky A, et al. Purinergic signalling in the nervous system: an overview. Trends Neurosci 2009;32:19-29.
4. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002;82:1013-1067.
5. Kawate T, Michel JC, Birdsong WT, et al. Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 2009;460:592-598.
6. Jarvis MF, Burgard EC, McGaraughty S, et al. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci U S A 2002;99:17179-17184. (Pubitemid 36034118)
7. Hausmann R, Rettinger J, Gerevich Z, et al. The suramin analog 4,4′,4″,4‴-(carbonylbis(imino-5,1,3-benzenetriylbis (carbonylimino)))tetra-kis-benzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups. Mol Pharmacol 2006;69:2058-2067.
8. Jung KY, Moon HD, Lee GE, et al. Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist. J Med Chem 2007;50:4543-4547.
9. Lewis RJ, Garcia ML. Therapeutic potential of venom peptides. Nat Rev Drug Discov 2003;2:790-802.
10. Chen CC, Akopian AN, Sivilotti L, et al. A P2X purinoceptor expressed by a subset of sensory neurons. Nature 1995;377:428-431.
11. Hargreaves K, Dubner R, Brown F, et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77-88.
12. Mouhat S, Jouirou B, Mosbah A, et al. Diversity of folds in animal toxins acting on ion channels. Biochem J 2004;378:717-726. (Pubitemid 38406846)
13. Pratt EB, Brink TS, Bergson P, et al. Use-dependent inhibition of P2X3 receptors by nanomolar agonist. J Neurosci 2005;25:7359-7365. (Pubitemid 41129808)
14. Xu GY, Huang LY. Peripheral inflammation sensitizes P2X receptor-mediated responses in rat dorsal root ganglion neurons. J Neurosci 2002;22:93-102. (Pubitemid 34033487)
15. Escoubas P, De Weille JR, Lecoq A, et al. Isolation of a tarantula toxin specific for a class of proton-gated Na+ channels. J Biol Chem 2000;275:25116-25121. (Pubitemid 30658753)
16. Diochot S, Baron A, Rash LD, et al. A new sea anemone peptide, APETx2, inhibits ASIC3, a major acid-sensitive channel in sensory neurons. EMBO J 2004;23:1516-1525. (Pubitemid 38579512)
17. Siemens J, Zhou S, Piskorowski R, et al. Spider toxins activate the capsaicin receptor to produce inflammatory pain. Nature 2006;444:208-212. (Pubitemid 44722061)
18. Andreev YA, Kozlov SA, Koshelev SG, et al. Analgesic compound from sea anemone Heteractis crispa is the first polypeptide inhibitor of vanilloid receptor 1 (TRPV1). J Biol Chem 2008;283:23914-23921.